Control Plasma Level 1

SECTION 2: Hazards identification

WHMIS 2015 Classification of the mixture

Hazard categories

Hazard statement Not classified For exposure limits see section 8 Potential adverse physicochemical, human health and environmental effects see also Ch. 9-12) Under normal conditions of use, the mixture does not cause adverse effects to the environment

Hazard pictograms

None

Signal word

None

Hazard statements

None

Precautionary statements

None Other labeling details: ≈ 100% of the mixture consists of component of unknown acute toxicity (oral, dermal, inhalation) for the human health and unknown hazard to the aquatic environment. Use the product in accordance with the Good Laboratory Practice. Wear suitable protective clothing, gloves and eye/face protection. Do not let the product enter drainage system, surface and ground-water or soil. Do not empty into drains.

Other hazards which do not result in classification

The mixture does not meet the criteria for PBT or vPvB. Warning: This product contains human source material that tested non-reactive for HIV antibody, Hepatitis B Surface Antigen and Anti- HCV at the donor stage. This product, as with all human based specimens, should be handled with proper laboratory safety procedures to minimize the risk of transmission of infectious disease.

2.1 Classification of the substance or mixture

This product is not hazardous according to Regulations (EC) No 1272/2008, Hazardous Product Regulations OSHA 29 CFR 1910.1200 and HPR (WHMIS 2015). Any additional information concerning the risks for health and/or the environment are given in sections 11 and 12 of this sheet. According to Regulations (EC) No 1272/2008, Hazard Communication Standard, 29 CFR 1910.1200 (HCS), and Hazardous Product Regulation HPR (WHMIS 2015): Hazard class Hazard category Hazard statement Not classified For exposure limits see section 8. Potential adverse physicochemical, human health and environmental effects (see also Ch. 9-12) Under normal conditions of use, the mixture does not cause adverse effects to the environment. 2.2 Label elements: According to Regulation (EC) No 1272/2008: Hazard pictogram(s): None Signal word(s): None Hazard statement(s): None Precautionary statement(s): None Other labeling details: ≈ 100% of the mixture consists of component of unknown acute toxicity (oral, dermal, inhalation) for the human health and unknown hazard to the aquatic environment. Use the product in accordance with the Good Laboratory Practice. Safety precautions: Wear suitable protective clothing, gloves and eye/face protection. Do not let the product enter drainage system, surface and ground-water or soil. Do not empty into drains. 2.3 Other hazards (which do not results in the classification) The mixture does not meet the criteria for PBT or vPvB. Warning: This product contains human source material that tested non-reactive for HIV antibody, Hepatitis B Surface Antigen and Anti- HCV at the donor stage. This product, as with all human based specimens, should be handled with proper laboratory safety procedures to minimize the risk of transmission of infectious disease. SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS Composition: solid containing organic and inorganic components, human plasma. 3.1 Hazardous components: no known hazardous ingredients. The mixture does not contain substances listed in the Hazardous Substance Lists and/or evaluated for carcinogenicity by IARC, NTP, OSHA. See Section 11 and 15. SECTION 4. FIRST AID MEASURES 4.1 Description of first aid measures Ingestion: If swallowed rinse mouth with plenty of water provided person is conscious. Do not induce vomiting. Get medical advice if adverse symptoms appear. Inhalation exposure: If inhaled, move person to fresh air. If breathing is difficult, oxygen should be administered. Get medical advice immediately (show the SDS or the label were possible). Contact with skin: Remove contaminated clothes and shoes. Wash immediately affected area with soap or mild detergent and plenty of water until the removal of the mixture (15-20 minutes). Get medical advice if adverse symptoms appear. Contact with eyes: Wash immediately with plenty of water or normal saline for at least 15 minutes. Keep eyelid open with the finger. Get medical advice if adverse symptoms appear. 4.2 Most important symptoms and effects (acute and delayed) Acute: Inhalation: May cause irritation to respiratory ways. Skin : May be irritant for skin. Eyes: May cause irritation. Ingestion: May cause irritation to the gastrointestinal mucous membranes. Delayed: Delayed symptoms and effects are not known. 4.3 Indication of any immediate medical attention and special treatment needed Medical monitoring: Not foreseen. Antidotes, if known: Not known. SECTION 5. FIRE-FIGHTING MEASURES 5.1 Extinguishing media Suitable extinguishing media: Water spray or regular foam, CO2, dry powder. Unsuitable extinguishing media